Detalles de la búsqueda
1.
Enhanced histamine H2 excitation of striatal cholinergic interneurons in L-DOPA-induced dyskinesia.
Neurobiol Dis;
76: 67-76, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25661301
2.
Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M1 agonists.
Bioorg Med Chem Lett;
25(19): 4158-63, 2015 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26299349
3.
Development of 2-aminooxazoline 3-azaxanthenes as orally efficacious ß-secretase inhibitors for the potential treatment of Alzheimer's disease.
Bioorg Med Chem Lett;
25(4): 767-74, 2015 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25613679
4.
Hydroxyethylamine-based inhibitors of BACE1: P1-P3 macrocyclization can improve potency, selectivity, and cell activity.
Bioorg Med Chem Lett;
23(15): 4459-64, 2013 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23769639
5.
Establishing the relationship between in vitro potency, pharmacokinetic, and pharmacodynamic parameters in a series of orally available, hydroxyethylamine-derived ß-secretase inhibitors.
J Pharmacol Exp Ther;
343(2): 460-7, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22911925
6.
Structure guided P1' modifications of HEA derived ß-secretase inhibitors for the treatment of Alzheimer's disease.
Bioorg Med Chem Lett;
22(11): 3607-11, 2012 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22572583
7.
Use of structure based design to increase selectivity of pyridyl-cinnoline phosphodiesterase 10A (PDE10A) inhibitors against phosphodiesterase 3 (PDE3).
Bioorg Med Chem Lett;
22(22): 6938-42, 2012 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23044369
8.
Discovery of potent, selective, and metabolically stable 4-(pyridin-3-yl)cinnolines as novel phosphodiesterase 10A (PDE10A) inhibitors.
Bioorg Med Chem Lett;
22(6): 2262-5, 2012 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22365755
9.
Nonspecificity of binding of gamma-secretase modulators to the amyloid precursor protein.
Biochemistry;
48(50): 11837-9, 2009 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-19928774
10.
Blood-brain barrier permeability considerations for CNS-targeted compound library design.
Curr Opin Chem Biol;
12(3): 318-23, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18435937
11.
Discovery of alpha-amidosulfones as potent and selective agonists of CB2: synthesis, SAR, and pharmacokinetic properties.
Bioorg Med Chem Lett;
19(1): 31-5, 2009 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19062274
12.
Structural modifications of N-arylamide oxadiazoles: Identification of N-arylpiperidine oxadiazoles as potent and selective agonists of CB2.
Bioorg Med Chem Lett;
18(15): 4267-74, 2008 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18640038
13.
An Orally Available BACE1 Inhibitor That Affords Robust CNS Aß Reduction without Cardiovascular Liabilities.
ACS Med Chem Lett;
6(2): 210-5, 2015 Feb 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-25699151
14.
Rapid identification of a novel small molecule phosphodiesterase 10A (PDE10A) tracer.
J Med Chem;
55(10): 4776-87, 2012 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-22548439
15.
Design and preparation of a potent series of hydroxyethylamine containing ß-secretase inhibitors that demonstrate robust reduction of central ß-amyloid.
J Med Chem;
55(21): 9009-24, 2012 Nov 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-22468639
16.
Design and synthesis of potent, orally efficacious hydroxyethylamine derived ß-site amyloid precursor protein cleaving enzyme (BACE1) inhibitors.
J Med Chem;
55(21): 9025-44, 2012 Nov 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-22468684
17.
Structure-brain exposure relationships.
J Med Chem;
49(26): 7559-83, 2006 Dec 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-17181137
18.
From fragment screening to in vivo efficacy: optimization of a series of 2-aminoquinolines as potent inhibitors of beta-site amyloid precursor protein cleaving enzyme 1 (BACE1).
J Med Chem;
54(16): 5836-57, 2011 Aug 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-21707077
19.
Discovery and optimization of a novel series of N-arylamide oxadiazoles as potent, highly selective and orally bioavailable cannabinoid receptor 2 (CB2) agonists.
J Med Chem;
51(16): 5019-34, 2008 Aug 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-18680277
20.
Structural modifications that alter the P-glycoprotein efflux properties of compounds.
J Med Chem;
55(11): 4877-95, 2012 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-22506484